Dynamized ultra-low dilution of Ruta graveolens disrupts plasma membrane organization and decreases migration of melanoma cancer cell.
Camille FuselierEleonore DufayAlexandre BerquandChristine TerrynArnaud BonnometMichael MolinariLaurent MartinyChristophe SchneiderPublished in: Cell adhesion & migration (2022)
Cutaneous melanoma is a cancer with a very poor prognosis mainly because of metastatic dissemination and therefore a deregulation of cell migration. Current therapies can benefit from complementary medicines as supportive care in oncology. In our study, we show that a dynamized ultra-low dilution of Ruta Graveolens leads to an in vitro inhibition of migration on fibronectin of B16F10 melanoma cells, as well as a decrease in metastatic dissemination in vivo . These effects appear to be due to a disruption of plasma membrane organization, with a change in cell and membrane stiffness, associated with a disorganization of the actin cytoskeleton and a modification of the lipid composition of the plasma membrane. Together, these results demonstrate, in in vitro and in vivo models of cutaneous melanoma, an anti-cancer and anti-metastatic activity of ultra-low dynamized dilution of Ruta graveolens and reinforce its interest as complementary medicine in oncology.
Keyphrases
- poor prognosis
- cell migration
- palliative care
- squamous cell carcinoma
- small cell lung cancer
- high resolution
- long non coding rna
- liquid chromatography tandem mass spectrometry
- liquid chromatography
- skin cancer
- healthcare
- gas chromatography
- single cell
- quality improvement
- basal cell carcinoma
- papillary thyroid
- bone marrow
- fatty acid
- chronic pain
- ms ms
- simultaneous determination